{"id":"https://openalex.org/W418774590","doi":null,"title":"Clinical Experience with Cefazolin in Large Doses Combined with Aminoglycoside in Blood Disease","display_name":"Clinical Experience with Cefazolin in Large Doses Combined with Aminoglycoside in Blood Disease","publication_year":1975,"publication_date":"1975-12-01","ids":{"openalex":"https://openalex.org/W418774590","mag":"418774590"},"language":"en","primary_location":{"id":"pmh:oai:irdb.nii.ac.jp:00828:0000990535","doi":null,"is_oa":true,"landing_page_url":"https://petit.lib.yamaguchi-u.ac.jp/1166","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u5c71\u53e3\u533b\u79d1\u5927\u5b66\u7d00\u8981","raw_type":"departmental bulletin paper"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://petit.lib.yamaguchi-u.ac.jp/1166","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"S. Oda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Oda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110032010","display_name":"Kunio Ariyoshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kunio Ariyoshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066432034","display_name":"Tadahiko SHIOMURA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Shiomura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003090612","display_name":"Mitsuaki Tajiri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitsuaki Tajiri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046429513","display_name":"Junichiro Ono","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junichiro Ono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Koji Nakashima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koji Nakashima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05861244,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"4","first_page":"693","last_page":"702"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefazolin","display_name":"cefazolin","score":1.0},{"id":"https://openalex.org/keywords/aminoglycosides","display_name":"aminoglycosides","score":0.8989999890327454},{"id":"https://openalex.org/keywords/gentamicin","display_name":"gentamicin","score":0.8970000147819519},{"id":"https://openalex.org/keywords/combination-antibiotic-therapy","display_name":"combination antibiotic therapy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/severe-infection","display_name":"serious infections","score":0.652999997138977},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8820000290870667},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8429999947547913},{"id":"https://openalex.org/keywords/gram-negative-bacilli","display_name":"Gram-negative bacilli","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cefazolin-resistance","display_name":"cefazolin resistance","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.9010000228881836},{"id":"https://openalex.org/keywords/drug-hypersensitivity","display_name":"drug hypersensitivity","score":0.5230000019073486},{"id":"https://openalex.org/keywords/exanthema","display_name":"exanthema","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C2778353156","wikidata":"https://www.wikidata.org/wiki/Q415739","display_name":"Cefazolin","level":3,"score":0.906599223613739},{"id":"https://openalex.org/C2777787772","wikidata":"https://www.wikidata.org/wiki/Q45355603","display_name":"Aminoglycoside","level":3,"score":0.7595702409744263},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6380742788314819},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5175506472587585},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3405121862888336},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.09678485989570618},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06876546144485474}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:irdb.nii.ac.jp:00828:0000990535","doi":null,"is_oa":true,"landing_page_url":"https://petit.lib.yamaguchi-u.ac.jp/1166","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u5c71\u53e3\u533b\u79d1\u5927\u5b66\u7d00\u8981","raw_type":"departmental bulletin paper"},{"id":"mag:418774590","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/120000865064","pdf_url":null,"source":{"id":"https://openalex.org/S2764811873","display_name":"The bulletin of the Yamaguchi Medical School/Bulletin of the Yamaguchi Medical School","issn_l":"0513-1812","issn":["0513-1812"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310313650","host_organization_name":"Yamaguchi University","host_organization_lineage":["https://openalex.org/P4310313650"],"host_organization_lineage_names":["Yamaguchi University"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u0098The \u009cbulletin of the Yamaguchi Medical School/Bulletin of the Yamaguchi Medical School","raw_type":null}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:00828:0000990535","doi":null,"is_oa":true,"landing_page_url":"https://petit.lib.yamaguchi-u.ac.jp/1166","pdf_url":null,"source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u5c71\u53e3\u533b\u79d1\u5927\u5b66\u7d00\u8981","raw_type":"departmental bulletin paper"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7143931334","https://openalex.org/W1481950828","https://openalex.org/W2067476398","https://openalex.org/W201974195","https://openalex.org/W1532280570","https://openalex.org/W2399188502","https://openalex.org/W1517452606","https://openalex.org/W2994150242","https://openalex.org/W2351630484","https://openalex.org/W2461458901"],"abstract_inverted_index":{"The":[0],"clinical":[1],"efficacy":[2],"of":[3,23,34,53,101,116,141],"cefazolin":[4,44,54,87,146],"(8-12g.":[5],"daily)":[6,56],"combined":[7,150],"with":[8,18,32,47,69,81,93,145,151],"amin-oglycoside":[9],"for":[10,121,138],"severe":[11,122],"infection":[12,33,80,123],"was":[13,28,39,57],"evaluated":[14],"in":[15,66,91,112,118,128],"20":[16],"patients":[17,31,92],"blood":[19,97],"diseases.":[20],"In":[21],"ten":[22],"twenty":[24],"patients,":[25],"therapeutic":[26],"success":[27],"achieved.":[29],"Three":[30],"which":[35,83],"the":[36,50,113],"causative":[37],"organism":[38],"not":[40,58],"detected":[41],"responded":[42],"to":[43,63,86,106,125],"alone":[45],"or":[46,95],"gentamicin.":[48],"But":[49],"usual":[51],"dose":[52,149],"(2-4g.":[55],"effective":[59],"against":[60],"infections":[61],"due":[62,124],"gram-negative":[64,126],"bacilli":[65,127],"a":[67],"patient":[68],"Hodgkin's":[70],"disease":[71],"although":[72],"there":[73],"were":[74,84,88,104,132],"sufficient":[75],"neutrophil":[76],"count.":[77],"As":[78],"mixed":[79],"organisms":[82,103],"insensitive":[85],"frequently":[89],"observed":[90],"neutropenia":[94],"malignant":[96],"diseases":[98],"and":[99],"most":[100],"cefazolin-insensitive":[102],"sensitive":[105],"aminoglycoside,":[107],"aminoglycoside":[108],"should":[109],"be":[110],"included":[111],"initial":[114],"therapy":[115],"CEZ":[117],"large":[119,148],"doses":[120],"these":[129],"patients.":[130],"There":[131],"no":[133],"significant":[134],"side":[135],"effects":[136],"except":[137],"one":[139],"case":[140],"generalized":[142],"exanthemas":[143],"associated":[144],"ill":[147],"aminoglycoside.":[152]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}